Larvol Delta - ViralClear-adds-St-David39s-HealthCare-in-Austin-Texas-to-its-planned-phase-II-trial-for-its-broadspectrum-oral-antiviral-candidate-for-Covid19

Vicromax (merimepodib) - BioSig Tech

https://www.globenewswire.com/news-release/2020/06/05/2044325/0/en/ViralClear-adds-St-David-s-HealthCare-in-Austin-Texas-to-its-Planned-Phase-II-trial-for-its-Broad-Spectrum-Oral-Anti-Viral-Candidate-for-COVID-19.html

Jun 5, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next